Avantor Inc
NYSE:AVTR

Watchlist Manager
Avantor Inc Logo
Avantor Inc
NYSE:AVTR
Watchlist
Price: 20.78 USD 2.06% Market Closed
Market Cap: 14.1B USD
Have any thoughts about
Avantor Inc?
Write Note

Avantor Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Avantor Inc
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Avantor Inc
NYSE:AVTR
Capital Expenditures
-$171.9m
CAGR 3-Years
-23%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Capital Expenditures
-$1.3B
CAGR 3-Years
17%
CAGR 5-Years
-8%
CAGR 10-Years
-14%
Danaher Corp
NYSE:DHR
Capital Expenditures
-$1.3B
CAGR 3-Years
-2%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Mettler-Toledo International Inc
NYSE:MTD
Capital Expenditures
-$95m
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Agilent Technologies Inc
NYSE:A
Capital Expenditures
-$369m
CAGR 3-Years
-34%
CAGR 5-Years
-18%
CAGR 10-Years
-7%
IQVIA Holdings Inc
NYSE:IQV
Capital Expenditures
-$617m
CAGR 3-Years
1%
CAGR 5-Years
-1%
CAGR 10-Years
-24%
No Stocks Found

Avantor Inc
Glance View

Market Cap
14.1B USD
Industry
Life Sciences Tools & Services

Avantor Inc. is a global leader in providing mission-critical products and services to customers in the life sciences and advanced technology sectors. Founded in 1904, the company has evolved from a small laboratory supply provider to a vital player in the biotechnology, pharmaceuticals, and diagnostics industries. With a portfolio of more than 10 million high-quality products, Avantor supports research and manufacturing needs across various environments, helping scientists and engineers push the boundaries of innovation. The firm prides itself on its commitment to sustainability and operational excellence, emphasizing an integrated supply chain that ensures reliable delivery and unmatched service. As an investor, understanding Avantor’s strategic positioning in a growing industry is crucial. With increasing global healthcare demands and rising investments in research and development, Avantor stands to benefit from the burgeoning life sciences market. The company's focus on digital transformation and efficiency improvements enhances its operational capabilities, while its strategic acquisitions have broadened its offerings and market reach. Furthermore, Avantor's consistent revenue growth and robust financial performance showcase a resilient business model, making it a compelling investment opportunity for those looking to capitalize on the future of scientific progress and innovation.

AVTR Intrinsic Value
24.89 USD
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Avantor Inc's Capital Expenditures?
Capital Expenditures
-171.9m USD

Based on the financial report for Sep 30, 2024, Avantor Inc's Capital Expenditures amounts to -171.9m USD.

What is Avantor Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-31%

Over the last year, the Capital Expenditures growth was -33%. The average annual Capital Expenditures growth rates for Avantor Inc have been -23% over the past three years , -31% over the past five years .

Back to Top